Glueck, C. J., Shah, P., Goldenberg, N., Prince, M., Lee, K., Jetty, V., . . . Wang, P. (2016). Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy. Lipids Health Dis.
Citação norma ChicagoGlueck, Charles J., Parth Shah, Naila Goldenberg, Marloe Prince, Kevin Lee, Vybhav Jetty, Ashwin Kumar, Michael Goldenberg, and Ping Wang. "Eligibility for PCSK9 Treatment in 734 Hypercholesterolemic Patients Referred to a Regional Cholesterol Treatment Center With LDL Cholesterol ≥70 mg/dl Despite Maximal Tolerated Cholesterol Lowering Therapy." Lipids Health Dis 2016.
MLA CitationGlueck, Charles J., et al. "Eligibility for PCSK9 Treatment in 734 Hypercholesterolemic Patients Referred to a Regional Cholesterol Treatment Center With LDL Cholesterol ≥70 mg/dl Despite Maximal Tolerated Cholesterol Lowering Therapy." Lipids Health Dis 2016.